|
Volumn 15, Issue 3, 2009, Pages 338-349
|
Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response.
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA2A INTERFERON;
ALPHA2B INTERFERON;
ANTIVIRUS AGENT;
MACROGOL DERIVATIVE;
PEGINTERFERON ALFA-2A;
PEGINTERFERON ALFA-2B;
PEGINTERFERON ALPHA2A;
PEGINTERFERON ALPHA2B;
RIBAVIRIN;
VIRUS RNA;
ADULT;
AGED;
ARTICLE;
DRUG COMBINATION;
FEMALE;
GENOTYPE;
HEPATITIS C;
HUMAN;
MALE;
MIDDLE AGED;
PATIENT COMPLIANCE;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIVIRAL AGENTS;
DRUG THERAPY, COMBINATION;
FEMALE;
GENOTYPE;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON ALFA-2A;
INTERFERON ALFA-2B;
MALE;
MIDDLE AGED;
PATIENT COMPLIANCE;
POLYETHYLENE GLYCOLS;
RIBAVIRIN;
RNA, VIRAL;
TREATMENT OUTCOME;
|
EID: 75349095239
PISSN: 1738222X
EISSN: None
Source Type: Journal
DOI: 10.3350/kjhep.2009.15.3.338 Document Type: Article |
Times cited : (6)
|
References (0)
|